Zobrazeno 1 - 10
of 95
pro vyhledávání: '"V. V. Omelyanovskiy"'
Autor:
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy
Publikováno v:
Фармакоэкономика, Vol 17, Iss 2, Pp 137-151 (2024)
Background. A wide range of endosurgical treatment methods in various medical care profiles and the need for uniformity of calculations required developing a unified approach to the formation of diagnosis-related groups (DRGs) for cases of surgical m
Externí odkaz:
https://doaj.org/article/1ee4740dc6484c9394652c0a32975376
Autor:
I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky
Publikováno v:
Фармакоэкономика, Vol 17, Iss 2, Pp 232-242 (2024)
Background. Determining the cost of laboratory tests is a significant factor in the context of economic analysis and management of clinical diagnostic laboratories. Information about costs allows medical organizations to plan operational activities m
Externí odkaz:
https://doaj.org/article/d7aa069604f64236ad5fa3b6ad43973a
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 671-680 (2024)
The article is devoted to the study of regulatory approaches to the sphere of real-world data (RWD) and real world evidence (RWE) in the countries of the Asia-Pacific Region (China, South Korea, Japan, Taiwan, etc.) and examples of their practical ap
Externí odkaz:
https://doaj.org/article/853acf45b342447abd3db6c338f51c2d
Autor:
V. V. Omelyanovskiy, V. K. Fediaeva
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 25-39 (2024)
Background. Health Technology Assessment (HTA) in the Russian Federation has been performed for drugs, not for other medical technologies, which leads to decision making difficulties today. Aim. This study aimed to assess the clinical and economic ef
Externí odkaz:
https://doaj.org/article/edf4819de846424db0cb7271eaf0cec6
Publikováno v:
Фармакоэкономика, Vol 16, Iss 3, Pp 363-374 (2023)
Background. Each constituent entity of the Russian Federation (RF) on the basis of the territorial programme of state guarantees of free medical care for citizens forms a tariff agreement (TA) on payment for medical care. Despite the list of requirem
Externí odkaz:
https://doaj.org/article/64f3934b68864f59b4d33c23baad479e
Autor:
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 196-208 (2023)
Background. In 2021, new clinical guidelines for the treatment of chronic hepatitis C virus (HCV) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic HCV is based on modern drugs of direct-acting
Externí odkaz:
https://doaj.org/article/14d3ca22b3b4442fae5a1a5d08f4f2cc
Autor:
V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 283-290 (2023)
The use of real-world data (RWD) and real-world evidence (RWE) in process of improving public health, their assessment, and use in decision making is a promising area. Discussions are actively underway about the possibility of using RWD and RWE in ro
Externí odkaz:
https://doaj.org/article/22c4e3a2073042ada0fe2ad109974e62
Autor:
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 266-282 (2023)
Background. The implementation of individual methods of high-tech medical care (HTMC) with methods of specialized medical care within the framework of a phased transition to payment methods by diagnostic-related groups (DRGs), on the one hand, signif
Externí odkaz:
https://doaj.org/article/bb5643db725e455292d5ad8767ae94a6
Publikováno v:
Фармакоэкономика, Vol 15, Iss 4, Pp 442-451 (2023)
Objective: development of a unified system and classification of indicators for an integral assessment of performance and effectiveness of the organization of medical care (MC) at the regional level in the Russian Federation (RF).Material and methods
Externí odkaz:
https://doaj.org/article/5c6e7ff52ff7409aaa116dcdb2145898
Publikováno v:
Фармакоэкономика, Vol 15, Iss 3, Pp 340-352 (2022)
Objevtive: to identify and systematize the main approaches to planning health care provider network used in foreign countries.Material and methods. Preliminary search for countries who had an experience of systematical planning of health care provide
Externí odkaz:
https://doaj.org/article/46ed70d1086b45e9b8f7daed470b1ad3